‌

US Patent 11673883 Heterocyclic compounds as immunomodulators

Patent 11673883 was granted and assigned to Incyte on June, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

June 13, 2023

0

Patent Application Number

170634070

Date Filed

October 5, 2020

0

Patent Citations

US Patent 9163017 Anti-viral compounds

0

US Patent 9540322 MIF modulators

0

US Patent 10017520 Myc modulators and uses thereof

0

US Patent 10202343 MIF modulators

0

US Patent 10308644 Heterocyclic compounds as immunomodulators

0

US Patent 10618916 Heterocyclic compounds as immunomodulators

0

US Patent 10669271 Heterocyclic compounds as immunomodulators

0

US Patent 10793505 Unit and process for purification of crude methyl methacrylate

0

...

Patent Citations Received

US Patent 12084443 Process of preparing a PD-1/PD-L1 inhibitor

0

US Patent 11866435 Heterocyclic compounds as immunomodulators

0

US Patent 11866434 Process for making a PD-1/PD-L1 inhibitor and salts and crystalline forms thereof

0

US Patent 11866451 Salts and crystalline forms of a PD-1/PD-L1 inhibitor

0

US Patent 11873309 Heterocyclic compounds as immunomodulators

0

Patent Primary Examiner

0

CPC Code

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11673883 Heterocyclic compounds as immunomodulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.